Literature DB >> 17439996

The prevalence of chronic fatigue syndrome in Nigeria.

Mary Gloriac C Njoku1, Leonard A Jason, Susan R Torres-Harding.   

Abstract

The present study found adult rates of chronic fatigue syndrome (CFS) in Nigeria that were somewhat higher than rates from community-based CFS epidemiologic studies in the USA. The rates of chronic fatigue for both adults and children were also higher than in existing community-based studies. It is possible that the presence of several fatiguing illnesses such as malaria and typhoid, the lack of adequate healthcare resources and poverty in Nigeria, place individuals at greater risk for fatigue and its syndromes. There is a need for more epidemiologic studies on the prevalence and sociodemographic characteristics of CFS in developing countries.

Entities:  

Mesh:

Year:  2007        PMID: 17439996     DOI: 10.1177/1359105307076233

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  14 in total

1.  A national cross-sectional survey of diagnosed sufferers of myalgic encephalomyelitis/chronic fatigue syndrome: pathways to diagnosis, changes in quality of life and service priorities.

Authors:  C Comiskey; F Larkan
Journal:  Ir J Med Sci       Date:  2010-09-26       Impact factor: 1.568

2.  Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Santiago Herrera; Wilfred C de Vega; David Ashbrook; Suzanne D Vernon; Patrick O McGowan
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

3.  Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project.

Authors:  Ann Vincent; Dana J Brimmer; Mary O Whipple; James F Jones; Roumiana Boneva; Brian D Lahr; Elizabeth Maloney; Jennifer L St Sauver; William C Reeves
Journal:  Mayo Clin Proc       Date:  2012-11-08       Impact factor: 7.616

4.  Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome.

Authors:  Emily G Lattie; Michael H Antoni; Mary Ann Fletcher; Frank Penedo; Sara Czaja; Corina Lopez; Dolores Perdomo; Andreina Sala; Sankaran Nair; Shih Hua Fu; Nancy Klimas
Journal:  Brain Behav Immun       Date:  2012-03-06       Impact factor: 7.217

5.  A natural history study of chronic fatigue syndrome.

Authors:  Leonard A Jason; Nicole Porter; Jessica Hunnell; Abigail Brown; Alfred Rademaker; Judith A Richman
Journal:  Rehabil Psychol       Date:  2011-02

6.  CFS: A Review of Epidemiology and Natural History Studies.

Authors:  Leonard A Jason; Nicole Porter; Molly Brown; Valerie Anderson; Abigail Brown; Jessica Hunnell; Athena Lerch
Journal:  Bull IACFS ME       Date:  2009

7.  Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.

Authors:  Luis C Nacul; Eliana M Lacerda; Derek Pheby; Peter Campion; Mariam Molokhia; Shagufta Fayyaz; Jose C D C Leite; Fiona Poland; Amanda Howe; Maria L Drachler
Journal:  BMC Med       Date:  2011-07-28       Impact factor: 8.775

8.  Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jose C de Carvalho Leite; Maria de L Drachler; Anne Killett; Swati Kale; Luis Nacul; Maggie McArthur; Chia Swee Hong; Lucy O'Driscoll; Derek Pheby; Peter Campion; Eliana Lacerda; Fiona Poland
Journal:  Int J Equity Health       Date:  2011-11-02

Review 9.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kjetil Gundro Brurberg; Marita Sporstøl Fønhus; Lillebeth Larun; Signe Flottorp; Kirsti Malterud
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

10.  The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis.

Authors:  Samantha Johnston; Ekua W Brenu; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Clin Epidemiol       Date:  2013-03-26       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.